Cresco Labs (updated as of June 2020)

CSE: CL // OTC: CRLBF

​

// investor presentation

​

note: share unlock information

note: pro-forma with Verdant

 

Structure -

 

fully diluted share count: 373,139,010

market cap: $1,809,724,198

​

Financials (Q1) -

​

last q reported revenue: $66,380,xxx
last q adj. ebitda: $17,134,xxx
last q total assets: $216,249,xxx
last q cash: $68,581,xxx
last q total liabilities: $141,190,xxx
last q net loss: $13,431,xxx
last q operating expenses: $46,653,xxx
last q gross margin: 30%

​

Licenses -

​

• 11 states

• 25/30 operational retail locations

• 13/18 operational production facilities

​

Arizona

operational: retail (1), production (2)

total: retail (1), production (2)

​

California

operational: retail (0), production (5)

total: retail (0), production (5)

​

Illinois

operational: retail (9), production (3)

total: retail (9), production (3)

note: co-located adult-use/medical dispensaries (4/5 stores) & cultivation (all 3 facilities)

​

Maryland

operational: retail (0), production (0)

total: retail (0), production (1)

note: financing/consulting agreement for a processing license

​

Massachusetts

operational: retail (1), production (1)

total: retail (3), production (1)

note: co-located adult-use/medical dispensary & production (Fall River)

​

Michigan

operational: retail (0), production (0)

total: retail (0), production (1)

note: details

​

Nevada

operational: retail (2), production (0)

total: retail (2), production (0)

note: 1.2% equity ownership interest

​

New York

operational: retail (4), production (0)

total: retail (4), production (1)

​

Ohio

operational: retail (5), production (1)

total: retail (5), production (2)

​

Pennsylvania

operational: retail (3), production (1)

total: retail (6), production (1)

​

Utah

operational: retail (0), production (0)

total: retail (0), production (1)

​

Footprint Map -